Herzpatienten und Höhenexposition
Abstract
Zusammenfassung. Herzpatientinnen und -patienten sollten bezüglich ihrer Toleranz gegenüber Höhe individuell beraten werden. Dabei sollte der historische Reflex, dass Höhe für Herzpatientinnen und -patienten per se schlecht sei, der Vergangenheit angehören. Adäquat behandelte und stabile Patientinnen und Patienten können meistens ohne jegliche Einschränkung bis in 2500 m Höhe gehen. Höhere Höhenlagen sind bei einer Vielzahl der Betroffenen ebenfalls möglich, bedürfen aber ggf. einer Anpassung der Medikation und weiterführender Abklärungen. Dies insbesondere, wenn in der grossen Höhe auch eine körperliche Leistung erbracht werden soll.
Abstract. Overall, heart patients should be advised individually with respect to their tolerance of altitudes. However, the historical reflex that altitude ’per se’ is bad for heart patients should become a thing of the past. Adequately treated and stable patients can usually go up to an altitude of 2500 m without any restrictions. Higher altitudes are also possible for a large number of patients, but may require an adaptation of the medication and further clarification. This is especially the case when physical work is to be performed at great heights.
Résumé. Dans l’ensemble, les patients doivent recevoir des conseils personnalisés sur leur tolérance d’une exposition à l’altitude. Cependant, le réflexe historique selon lequel l’altitude est mauvaise en soi pour les patients cardiaques devrait appartenir au passé. Les patients correctement traités et stables peuvent généralement aller jusqu’à 2500 m d’altitude sans aucune restriction. Des altitudes plus élevées sont également possibles pour un grand nombre de patients, mais peuvent nécessiter un ajustement du médicament et des précisions supplémentaires. Cela est particulièrement vrai lorsque du travail physique doit être effectué à de grandes altitudes.
Bibliografie
. Control of coronary blood flow during hypoxemia. Adv Exp Med Biol. 2007;618:25–39.
. Going to high altitude with heart disease. Cardiovasc Med. 2017;20:87–95.
, High-altitude exposure in patients with cardiovascular disease: risk assessment and practical recommendations. Prog Cardiovasc Dis. 2010;52(6): 512–524.
. Augmented vasoreactivity in adult life associated with perinatal vascular insult. Lancet. 1999;353(9171):2205–2207.
, Systemic and pulmonary vascular dysfunction in children conceived by assisted reproductive technologies. Circulation. 2012;125(15):1890–1896.
, Determinants of erythropoietin release in response to short-term hypobaric hypoxia. J Appl Physiol. (1985). 2002;92(6):2361–2367.
. Increased left ventricular muscle mass after long-term altitude training in athletes. Acta Physiol Scand. 1997;161(1):63–70.
, Fitness to fly for passengers with cardiovascular disease. Heart. 2010; 96. Suppl 2:ii1–16.
. Richards Lecture: Circulatory adjustments to hypoxia. Circulation, 1980;61(3):463–470.
. Control of the myocardial contractile state by carotid chemo – and baroreceptor and pulmonary inflation reflexes in conscious dogs. J Clin Invest. 1978;61(6): 1593–1601.
. A role for the carotid body in cardiovascular control in man. Chest. 1973;63(5):744–750.
. Circulatory responses to graded stimulation of the carotid chemoreceptors in the dog. Circ Res. 1972;31(3): 431–443.
. Hypoxic pulmonary vasoconstriction. Physiologic significance, mechanism, and clinical relevance. Chest. 1990;97(3):706–718.
. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax. 2002;57 (4):289–304.
. Medical Guidelines for Air Travel. Aerospace Medical Association, Air Transport Medicine Committee, Alexandria, Va. Aviat Space Environ Med. 1996;67(10 Suppl):B1–16.
. The use of pulmonary function testing in piloting, air travel, mountain climbing, and diving. Clin Chest Med. 2001;22(4):795–816.
, Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine. Eur Heart J. 2018;39(17):1546–1554.
, Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia. Eur J Heart Fail. 2006;8(7):729–735.
, Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects. Cardiovasc Ther. 2012;30(4):240–248.
; Swiss National Cohort Study Group. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation. 2009;120(6): 495–501.
. Influence of altitude exposure on coronary flow reserve. Circulation. 2003;108(10):1202–1207.
. Safety and exercise tolerance of acute high altitude exposure (3454 m) among patients with coronary artery disease. Heart. 2006;92(7):921–925.
, Impact of high altitude on echocardiographically determined cardiac morphology and function in patients with coronary artery disease and healthy controls. Eur J Echocardiogr. 2010.11(5):446–450.
, Effects of altitude on exercise level and heart rate in patients with coronary artery disease and healthy controls. Neth Heart J. 2010;18(3):118–121.
, Correlation between blood pressure changes and AMS, sleeping quality and exercise upon high-altitude exposure in young Chinese men. Mil Med Res. 2014;1:19.
, Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial. Eur Heart J. 2014;35(44):3113–3122.
, Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude. J Hypertens. 2011; 29(2):380–287.
, Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad. High Alt Med Biol. 2007;8(2):88–107.
, Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study. Hypertension. 2015;65(6):1266–1272.
, Influence of acute exposure to high altitude and hypoxemia on ventricular stimulation thresholds in pacemaker patients. Pacing Clin Electrophysiol. 2000;23(4 Pt 1):512–515.
, Cardiopulmonary adaptation to short-term high altitude exposure in adult Fontan patients. Heart. 2016;102(16):1296–1301.
, Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions. Eur Heart J. 2019;40(20): 1590–1596.
, Long term exposure to ambient air pollution and incidence of acute coronary events: prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE Project. BMJ. 2014;348: f7412.
, Hourly exposure to ultrafine particle metrics and the onset of myocardial infarction in Augsburg, Germany. Environ Health Perspect. 2020;128(1): 17003.
, Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy. J Allergy Clin Immunol. 2019;143(3):1077–1086e10.
, The effects of air pollution on COVID-19 related mortality in Northern Italy. Environ Resour Econ (Dordr). 2020:1–24.
